About
Brightlands Venture Partners (BVP) is an institutional venture capital firm with deep expertise in sustainability and health sectors. Founded to provide pivotal funding to earlystage companies tackling complex societal challenges, BVP manages four funds with a total capital commitment of €120 million. These funds include Limburg Ventures founded in 2004, Chemelot Ventures founded in 2014, Brightlands Agrifood Fund founded in 2017, and BVP Fund IV established in April 2021. The firm is headquartered in Geleen, Netherlands, with a secondary location in Venlo. Notable companies in its portfolio include Vivalyx, which aims to improve donor organ quality, and Matisse Pharmaceuticals, which focuses on treatments for critically ill sepsis patients.